1.Hypopituitarism in a Dengue Shock Syndrome Survivor without known Pituitary Adenoma
Lim, L.L. ; Ibrahim, L. ; Paramasivam, S.S. ; Ratnasingam, J. ; Chan, S.P. ; Tan, A.T.B. ; Vethakkan, S.R.
Tropical Biomedicine 2016;33(4):746-752
Dengue infection is endemic in South East Asia and parts of the Americas. Dengue
hemorrhagic fever is characterized by vascular permeability, coagulation-disorders and
thrombocytopenia, which can culminate in hypotension i.e. dengue shock syndrome.
Hypopituitarism arising as a complication of dengue is extremely rare. Hemorrhagic pituitary
apoplexy of pre-existing pituitary adenomas has been rarely reported in dengue. We describe
an uncommon case of hypopituitarism in a dengue shock syndrome survivor without known
pituitary adenoma. A 49 years old nulliparous lady (from Kuala Lumpur, Malaysia) presented
with typical symptoms of hypocortisolism. Postural hypotension was evident with normal
secondary sexual characteristics. Further history revealed that she survived an episode of
dengue shock syndrome 6 years ago where premature menopause developed immediately
after discharge, and subsequently insidious onset of multiple hormonal deficiencies indicative
of panhypopituitarism. There were no neuro-ophthalmological symptoms suggestive of pituitary
apoplexy during hospitalization for severe dengue. Magnetic resonance imaging of the pituitary
6 years later revealed an empty sella. Autoimmune screen and anti-thyroid peroxidase
antibodies were negative. We describe a rare possible causative association of severe dengue
with panhypopituitarism without known pituitary adenoma, postulating pituitary infarction
secondary to hypotension (mimicking Sheehan’s syndrome), or a direct viral cytopathic effect.
Subclinical pituitary apoplexy secondary to asymptomatic pituitary hemorrhage however
cannot be excluded. Future research is required to determine the need for and timing of
pituitary axis assessment among dengue shock syndrome survivors.
2.Reduced Fertility and Fecundity among Patients with Bipolar I Disorder and Schizophrenia in Egypt.
Hader MANSOUR ; Kareem KANDIL ; Joel WOOD ; Warda FATHI ; Mai ELASSY ; Ibtihal IBRAHIM ; Hala SALAH ; Amal YASSIN ; Hanan ELSAYED ; Salwa TOBAR ; Hala EL-BORAIE ; Ahmed EISSA ; Mohamed ELHADIDY ; Nahed E IBRAHIM ; Wafaa EL-BAHAEI ; Vishwajit L NIMGAONKAR
Psychiatry Investigation 2011;8(3):214-220
OBJECTIVE: To evaluate reproduction among patients with bipolar I disorder (BP1) or schizophrenia (SZ) in Egypt. METHODS: BP1 patients (n=113) were compared with community based, demographically balanced controls (n=124) and SZ patients (n=79, DSM-IV). All participants were evaluated using structured interviews and corroborative data were obtained from relatives. Standard indices of procreation were included in multivariate analyses that incorporated key demographic variables. RESULTS: Control individuals were significantly more likely to have children than BP1 or SZ patients (controls 46.8%, BP1 15.9%, SZ 17.7%), but the BP1-SZ differences were non-significant. The average number of children for BP1 patients (0.37+/-0.9) and SZ patients (0.38+/-0.9) was significantly lower than for controls (1.04+/-1.48) (BP1 vs controls, p<0.001; SZ vs controls, p<0.001). The frequency of marriages among BP1 patients was nominally higher than the SZ group, but was significantly lower than controls (BP1: 31.9% SZ: 27.8% control: 57.3%). Even among married individuals, BP1 (but not SZ) patients were childless more often than controls (p=0.001). The marital fertility, i.e., the average number of children among patients with conjugal relationships for controls (1.8+/-1.57) was significantly higher than BP1 patients (1.14+/-1.31, p=0.02), but not significantly different from SZ patients (1.36+/-1.32, p=0.2). CONCLUSION: Selected reproductive measures are significantly and substantially reduced among Egyptian BP1 patients. The reproductive indices are similar among BP1 and SZ patients, suggesting a role for general illness related variables. Regardless of the cause/s, the impairment constitutes important, under-investigated disability.
Bipolar Disorder
;
Child
;
Egypt
;
Fertility
;
Humans
;
Marriage
;
Multivariate Analysis
;
Reproduction
;
Schizophrenia
3.Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine..
Bukhtiar H SHAH ; Huma RASHEED ; Ibrahim H RAHMAN ; Amir H SHARIFF ; Fatima L KHAN ; Hina B RAHMAN ; Sara HANIF ; Sheikh A SAEED
Experimental & Molecular Medicine 2001;33(4):226-233
Our recent studies have shown that co-activation of Gq and Gi proteins by 5-hydroxytryptamine (5-HT) and adrenaline show synergism in human platelet aggregation. This study was conducted to examine the mechanism(s) of synergistic interaction of 5-HT and platelet activating factor (PAF) in human platelets. We show that PAF, but not 5-HT, increased platelet aggregation in a concentration-dependent manner. However, low concentrations of 5-HT (2 microM) potentiated platelet aggregation induced by subthreshold concentration of PAF (40 nM) indicating a synergistic interaction between the two agonists and this synergism was blocked by receptor antagonists to either 5-HT or PAF. 5-HT also potentiated the effect of PAF on thromboxane A2 (TXA2) formation and phosphorylation of extracellularly regulated mitogen-activated protein kinases (ERK1/2). The synergism of 5-HT and PAF in platelet aggregation was inhibited by calcium (Ca2+) channel blockers, verapamil and diltiazem, phospholipase C (PLC) inhibitor, U73122, cyclooxygenase (COX) inhibitor, indomethacin, and MEK inhibitor, PD98059. These data suggest that synergistic effect of 5-HT and PAF on human platelet aggregation involves activation of PLC/Ca2+, COX and MAP kinase pathways.
Diltiazem/pharmacology
;
Dose-Response Relationship, Drug
;
Drug Synergism
;
Estrenes/pharmacology
;
Flavones/pharmacology
;
Human
;
In Vitro
;
Indomethacin/pharmacology
;
Kinetics
;
Mitogen-Activated Protein Kinases/metabolism
;
Phosphorylation/drug effects
;
Platelet Activating Factor/*pharmacology
;
Platelet Activation/drug effects
;
Platelet Aggregation/*drug effects/physiology
;
Pyrrolidinones/pharmacology
;
Serotonin/*pharmacology
;
Thromboxane A2/biosynthesis
;
Verapamil/pharmacology
4.Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine..
Bukhtiar H SHAH ; Huma RASHEED ; Ibrahim H RAHMAN ; Amir H SHARIFF ; Fatima L KHAN ; Hina B RAHMAN ; Sara HANIF ; Sheikh A SAEED
Experimental & Molecular Medicine 2001;33(4):226-233
Our recent studies have shown that co-activation of Gq and Gi proteins by 5-hydroxytryptamine (5-HT) and adrenaline show synergism in human platelet aggregation. This study was conducted to examine the mechanism(s) of synergistic interaction of 5-HT and platelet activating factor (PAF) in human platelets. We show that PAF, but not 5-HT, increased platelet aggregation in a concentration-dependent manner. However, low concentrations of 5-HT (2 microM) potentiated platelet aggregation induced by subthreshold concentration of PAF (40 nM) indicating a synergistic interaction between the two agonists and this synergism was blocked by receptor antagonists to either 5-HT or PAF. 5-HT also potentiated the effect of PAF on thromboxane A2 (TXA2) formation and phosphorylation of extracellularly regulated mitogen-activated protein kinases (ERK1/2). The synergism of 5-HT and PAF in platelet aggregation was inhibited by calcium (Ca2+) channel blockers, verapamil and diltiazem, phospholipase C (PLC) inhibitor, U73122, cyclooxygenase (COX) inhibitor, indomethacin, and MEK inhibitor, PD98059. These data suggest that synergistic effect of 5-HT and PAF on human platelet aggregation involves activation of PLC/Ca2+, COX and MAP kinase pathways.
Diltiazem/pharmacology
;
Dose-Response Relationship, Drug
;
Drug Synergism
;
Estrenes/pharmacology
;
Flavones/pharmacology
;
Human
;
In Vitro
;
Indomethacin/pharmacology
;
Kinetics
;
Mitogen-Activated Protein Kinases/metabolism
;
Phosphorylation/drug effects
;
Platelet Activating Factor/*pharmacology
;
Platelet Activation/drug effects
;
Platelet Aggregation/*drug effects/physiology
;
Pyrrolidinones/pharmacology
;
Serotonin/*pharmacology
;
Thromboxane A2/biosynthesis
;
Verapamil/pharmacology
5.The Philippine National Ear Institute: Patient and audilogic profiles
Generoso T Abes ; Abner L Chan ; Maria Rina Reyes-Quintos ; Rodante A Roldan ; Scheherazade C Ibrahim ; Genilou Liv M Gimena ; Charina Melinda C Elgar ; Ma Luz M San Agustin ; Charlotte M Chiong ; Regie Lyn P Santos-Cortez
Philippine Journal of Otolaryngology Head and Neck Surgery 2007;22(1-2):12-18
Background: The Philippine National Ear Institute (PNEI) was created to promote health of hearing and balance among Filipinos. Over the years, it has provided audiologic services to thousands of patients annually and has published relevant hearing and balance research. Objective: To describe the patients served by the PNEI in terms of age, region of origin, occupation, pretest diagnosis, and audiologic results. Methods: Study Design - Cross-sectional study Setting - National tertiary care center Population - All records of patients referred for audiologic testing at PNEI in 2006 were reviewed and encoded into analyzable format. Results: A total of 1,756 patients had audiologic records for review. Median age was 32.5 years, with the age distribution presented according to sex, type of tests done including common reasons for referral, and median threshold levels by frequency. Coverage was national in scope, with most patients coming from the National Capital Region and from Regions III and IVa. Occupation was indicated in 37.8 percent of the working age group, most of whom were unemployed. The most common pretest diagnosis was chronic otitis media (26.6 percent), followed by hearing loss of unknown etiology (13.0 percent) and tinnitus (9.3 percent). Severity of hearing impairment based on pure tone audiometry was variable, and was presented according to common diagnoses. About 39 percent of hearing impairment cases were sensorineural, 36 percent conductive and 25 percent due to mixed defect. Bilateral Type A ears were found in 45.4 percent of patients by tympanometry, while 29.3 percent were bilateral Type B. For otoacoustic emissions, 69.0 percent were labeled as "refer" in at least one ear. Conclusion: The PNEI is a major national referral center for audiology that holds much promise in developing programs for national surveillance of the hearing status of different sectors in Philippine society. (Author)
HEARING AUDIOLOGY ACOUSTIC IMPEDANCE TESTS OTITIS MEDIA
6.Purification of Plasmodium and Babesia- infected erythrocytes using a non-woven fabric filter
Tao, Z.Y. ; Liu, W.P. ; Dong, J. ; Feng, X.X. ; Yao, D.W. ; Lv, Q.L. ; Ibrahim, U. ; Dong, J.J. ; Culleton, R. ; Gu, W. ; Su, P.P. ; Tao, L. ; Li, J.Y. ; Fang, Q. ; Xia, H.
Tropical Biomedicine 2020;37(No.4):911-918
The purification of parasite-infected erythrocytes from whole blood containing
leucocytes is crucial for many downstream genetic and molecular assays in parasitology.
Current methodologies to achieve this are often costly and time consuming. Here, we
demonstrate the successful application of a cheap and simple Non-Woven Fabric (NWF) filter
for the purification of parasitized red blood cells from whole blood. NWF filtration was
applied to the malaria-parasitized blood of three strains of mice, and one strain of rat, and to
Babesia gibsoni parasitized dog blood. Before and after filtration, the white blood cell (WBC)
removal rates and red blood cell (RBC) recovery rates were measured. After NWF filter
treatment of rodent malaria-infected blood, the WBC removal rates and RBC recovery rates
were, for Kunming mice: 99.51%±0.30% and 86.12%±8.37%; for BALB/C mice: 99.61%±0.15%
and 80.74%±7.11%; for C57 mice: 99.71%±0.12% and 84.87%±3.83%; for Sprague-Dawley rats:
99.93%±0.03% and 83.30%±2.96%. Microscopy showed WBCs were efficiently removed from
infected dog blood samples, and there was no obvious morphological change of B. gibsoni
parasites. NWF filters efficiently remove leukocytes from malaria parasite-infected mouse
and rat blood, and are also suitable for filtration of B. gibsoni-infected dog blood.